|
|
Modeling androgen-independent prostate cancer in mutant mice
|
5R01CA115717-04
|
$305,900
|
$76,475
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-12
|
$729,463
|
$729,463
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Modeling Prostate Tumorigenesis
|
5R01CA094858-08
|
$230,554
|
$115,277
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
Risk factors for site-specific metastasis in esophageal cancer
|
5K07CA132892-03
|
$135,351
|
$135,351
|
Abrams, Julian
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Effects of Sema3A-Nrp1 signaling on tumor cell extravastion and metastasis
|
1K01CA148897-01
|
$106,251
|
$106,251
|
Acevedo, Lisette
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Biophysical studies of oncogenic Cdc42Hs constructs
|
5K01CA113753-04
|
$143,635
|
$143,635
|
ADAMS, PAUL
|
UNIVERSITY OF ARKANSAS AT FAYETTEVILLE
|
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
2R01CA109339-06A1
|
$306,320
|
$76,580
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
3U54CA091408-10S1
|
$300,000
|
$45,000
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-10
|
$1,949,820
|
$292,473
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis
|
5R01CA124940-04
|
$250,515
|
$82,670
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
|
Functional Determinants of Metastatic Dormancy
|
2R01CA109182-07
|
$326,938
|
$326,938
|
AGUIRRE-GHISO, JULIO
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
|
Signal Transduction Pathways in Melanoma
|
5R01CA118972-04
|
$268,392
|
$214,714
|
AHN, NATALIE
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-05
|
$754,460
|
$188,615
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
5K23CA127141-03
|
$140,940
|
$70,470
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Mechanisms of T cell leukemia induction and maintenance
|
1R01CA149655-01
|
$350,675
|
$350,675
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-04
|
$292,084
|
$73,021
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
5R01CA120552-05
|
$248,463
|
$248,463
|
AKPORIAYE, EMMANUEL
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
|
Modeling causes and consequences of the evolution of cell motility in neoplasms
|
1F32CA144331-01
|
$50,474
|
$50,474
|
Aktipis, Christina
|
UNIVERSITY OF ARIZONA
|
|
|
A Novel Regulator of Cancer Cell Migration and Invasion
|
5R01CA115706-05
|
$195,792
|
$195,792
|
ALAHARI, SURESH
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
$9,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
$12,950
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
$9,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
$374,571
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-03
|
$270,000
|
$270,000
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Characterization of WWOX, the Cancer Gene Spanning FRA16D
|
2R01CA102444-06A1
|
$343,332
|
$343,332
|
Aldaz, Claudio
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
5K25CA129173-02
|
$128,715
|
$64,358
|
Ali, Md
|
HENRY FORD HEALTH SYSTEM
|
|
|
Cellular MRI in Glioma and Radiation Necrosis
|
5R01CA122031-04
|
$247,950
|
$148,770
|
ALI, SYED
|
HENRY FORD HEALTH SYSTEM
|
|
|
Role of Vitamin D Receptor Polymorphisms in Breast Cancer
|
5F31CA132619-03
|
$36,828
|
$36,828
|
Alimirah, Fatouma
|
ILLINOIS INSTITUTE OF TECHNOLOGY
|
|
|
A Human Intraepithelial Tumor Microenvironment Assay
|
2R42CA118684-02A2
|
$614,540
|
$614,540
|
Allen-Hoffmann, Barbara
|
STRATATECH CORPORATION
|
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-05
|
$340,950
|
$340,950
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
1P01CA140043-01A1
|
$1,242,575
|
$621,288
|
ALTIERI, DARIO
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-41S2
|
$99,294
|
$8,936
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-41
|
$2,527,733
|
$227,496
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-11
|
$288,775
|
$288,775
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
7R21CA129302-02
|
$208,628
|
$208,628
|
Altomare, Deborah
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
|
The Molecular Profile of Prostate Tumors in Smokers
|
ZIA BC 010660
|
$66,613
|
$66,613
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Dietary Prevention of Cancer
|
3R01CA109269-07S1
|
$81,290
|
$20,323
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
Dietary Prevention of Cancer
|
5R01CA109269-07
|
$283,480
|
$70,870
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
1R25CA153954-01
|
$335,580
|
$83,895
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
|
PI Signaling Role in Epithelial/Mesenchymal Transition
|
2R01CA104708-06A2
|
$297,310
|
$297,310
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
4R00CA131489-03
|
$248,999
|
$124,500
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$341,428
|
$68,286
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-03
|
$167,791
|
$167,791
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
B-RAF Regulation of the Cell Cycle in Melanoma
|
5R01CA125103-04
|
$256,470
|
$256,470
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Synthetic Biological Devices for Understanding the Effect of Hypoxia on Cancer Ce
|
1F32CA154195-01
|
$47,606
|
$23,803
|
Armel, Thomas
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
|
SPORE in Breast Cancer
|
5P50CA098131-08
|
$2,190,230
|
$547,558
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
|
Activated nano-sized MR contrast agents for imaging of tumor proteolytic activity
|
5R21CA133288-02
|
$216,480
|
$216,480
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Quantitative analysis of epithelial cell scatter
|
1R01CA138899-01A2
|
$318,047
|
$318,047
|
ASTHAGIRI, ANAND
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-07
|
$2,300,000
|
$575,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Characterization of the p53 Apoptotic Target Gene Perp
|
5R01CA093665-09
|
$284,630
|
$142,315
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Total relevant funding to Metastasis for this search: $385,223,790
|
